IBDEI1X2 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30611,0)
 ;;=93225^^122^1574^4^^^^1
 ;;^UTILITY(U,$J,358.3,30611,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30611,1,2,0)
 ;;=2^ECG Monitor < 48hrs,Recording Only
 ;;^UTILITY(U,$J,358.3,30611,1,3,0)
 ;;=3^93225
 ;;^UTILITY(U,$J,358.3,30612,0)
 ;;=93226^^122^1574^1^^^^1
 ;;^UTILITY(U,$J,358.3,30612,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30612,1,2,0)
 ;;=2^ECG Monitor < 48hrs,Analysis & Rpt
 ;;^UTILITY(U,$J,358.3,30612,1,3,0)
 ;;=3^93226
 ;;^UTILITY(U,$J,358.3,30613,0)
 ;;=93227^^122^1574^2^^^^1
 ;;^UTILITY(U,$J,358.3,30613,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30613,1,2,0)
 ;;=2^ECG Monitor < 48hrs,Intrp
 ;;^UTILITY(U,$J,358.3,30613,1,3,0)
 ;;=3^93227
 ;;^UTILITY(U,$J,358.3,30614,0)
 ;;=36245^^122^1575^1^^^^1
 ;;^UTILITY(U,$J,358.3,30614,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30614,1,2,0)
 ;;=2^Ins Cath Abd/L-Ext Art,1st
 ;;^UTILITY(U,$J,358.3,30614,1,3,0)
 ;;=3^36245
 ;;^UTILITY(U,$J,358.3,30615,0)
 ;;=96523^^122^1575^2^^^^1
 ;;^UTILITY(U,$J,358.3,30615,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30615,1,2,0)
 ;;=2^Irrig Drug Delivery Device
 ;;^UTILITY(U,$J,358.3,30615,1,3,0)
 ;;=3^96523
 ;;^UTILITY(U,$J,358.3,30616,0)
 ;;=99366^^122^1576^1^^^^1
 ;;^UTILITY(U,$J,358.3,30616,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30616,1,2,0)
 ;;=2^Med Team Conf FTF > 29 min
 ;;^UTILITY(U,$J,358.3,30616,1,3,0)
 ;;=3^99366
 ;;^UTILITY(U,$J,358.3,30617,0)
 ;;=99367^^122^1576^2^^^^1
 ;;^UTILITY(U,$J,358.3,30617,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30617,1,2,0)
 ;;=2^Med Team Conf w/o FTF;Physician
 ;;^UTILITY(U,$J,358.3,30617,1,3,0)
 ;;=3^99367
 ;;^UTILITY(U,$J,358.3,30618,0)
 ;;=99368^^122^1576^3^^^^1
 ;;^UTILITY(U,$J,358.3,30618,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,30618,1,2,0)
 ;;=2^Med Team Conf w/o FTF;Nonphysician
 ;;^UTILITY(U,$J,358.3,30618,1,3,0)
 ;;=3^99368
 ;;^UTILITY(U,$J,358.3,30619,0)
 ;;=Z49.31^^123^1577^1
 ;;^UTILITY(U,$J,358.3,30619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30619,1,3,0)
 ;;=3^Adequacy Testing for Hemodialysis
 ;;^UTILITY(U,$J,358.3,30619,1,4,0)
 ;;=4^Z49.31
 ;;^UTILITY(U,$J,358.3,30619,2)
 ;;=^5063058
 ;;^UTILITY(U,$J,358.3,30620,0)
 ;;=N18.6^^123^1577^3
 ;;^UTILITY(U,$J,358.3,30620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30620,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,30620,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,30620,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,30621,0)
 ;;=Z99.2^^123^1577^2
 ;;^UTILITY(U,$J,358.3,30621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30621,1,3,0)
 ;;=3^Dependence on Renal Dialysis
 ;;^UTILITY(U,$J,358.3,30621,1,4,0)
 ;;=4^Z99.2
 ;;^UTILITY(U,$J,358.3,30621,2)
 ;;=^5063758
 ;;^UTILITY(U,$J,358.3,30622,0)
 ;;=Z91.15^^123^1577^4
 ;;^UTILITY(U,$J,358.3,30622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30622,1,3,0)
 ;;=3^Patient's Noncompliance w/ Renal Dialysis
 ;;^UTILITY(U,$J,358.3,30622,1,4,0)
 ;;=4^Z91.15
 ;;^UTILITY(U,$J,358.3,30622,2)
 ;;=^5063617
 ;;^UTILITY(U,$J,358.3,30623,0)
 ;;=Z49.32^^123^1578^1
 ;;^UTILITY(U,$J,358.3,30623,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30623,1,3,0)
 ;;=3^Adequacy Testing for Peritoneal Dialysis
 ;;^UTILITY(U,$J,358.3,30623,1,4,0)
 ;;=4^Z49.32
 ;;^UTILITY(U,$J,358.3,30623,2)
 ;;=^5063059
 ;;^UTILITY(U,$J,358.3,30624,0)
 ;;=N18.6^^123^1578^2
 ;;^UTILITY(U,$J,358.3,30624,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30624,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,30624,1,4,0)
 ;;=4^N18.6
